Novo Nordisk A/S ADR buy Argus
Start price
02.10.23
/
50%
€85.60
Target price
02.10.24
€104.76
Performance (%)
22.66%
End price
03.10.24
€105.00
Summary
This prediction ended on 03.10.24 with a price of €105.00. The prediction had a final performance of 22.66%. Dividends of €1.08 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 0.965% | 0.965% | -37.290% |
| iShares Core DAX® | 1.130% | 2.184% | 15.737% |
| iShares Nasdaq 100 | 1.128% | -0.611% | 7.324% |
| iShares Nikkei 225® | 2.610% | 4.958% | 20.446% |
| iShares S&P 500 | -0.006% | -0.952% | 2.166% |
Comments by Argus for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at Argus. They set a "buy" rating and a $110.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von Argus gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Argus for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€132.00
10.06.24
10.06.24
€148.83
10.06.25
10.06.25
-47.35%
11.06.25
11.06.25
